Floatz logo

Monomethyl Fumarate

Liver Cirrhosis

Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanSmall moleculePhase 3Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
73/ 100

Competitive context

49 Active assets in the Liver Cirrhosis cohort.

Asset / SponsorPhaseRating
Rifaximin
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4BBB
SIMVASTATIN
Chang Gung Memorial Hospital
Phase 4BBB
WARFARIN
Kafrelsheikh University
Phase 4BB
Entecavir
Third Affiliated Hospital, Sun Yat-Sen University
Phase 4BB
Thymosin-̑
Beijing Friendship Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →